knowledge -WSS

knowledge

author：Wikipedia 2025-09-30 18:00:34 - browse：25

green electrocardiogram scan. -- health tech coverage from STAT — Adobe

As Bristol Myers Squibb works to build its treatment for a heart condition that can cause difficulty breathing into a blockbuster drug, it’s propped up an algorithm designed to help find more people who are affected.

The algorithm, which is part of software developed by Viz.ai, earlier this month received clearance from the Food and Drug Administration. The tool, called Viz HCM, looks at 12-lead electrocardiograms collected during routine care and flags suspected cases of hypertrophic cardiomyopathy, or HCM, for further evaluation. As part of a multi-year agreement between the companies, BMS — whose drug, Camzyos, is used to treat HCM — provided funding and scientific input for the development of the algorithm.

“BMS has a vested interest in finding more patients with HCM,” said Matthew Martinez, a cardiologist who leads Viz.ai’s HCM medical advisory board. “Why? Because they’re so philanthropic? No, they want to sell more drugs. They want to help more people by identifying more people.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Why depression after traumatic brain injury is distinct

leisure time

WSS

2 officers injured in shooting in Orlando, police say

When waiting feels immoral: Empathy in the emergency department

When waiting feels immoral: Empathy in the emergency department

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

FDA advisers back CAR

Steward Health Care Massachusetts hospitals face fiscal disaster

hotspot

knowledge

focus

Anesthesiologist group: stop taking Ozempic before surgery

Biotech startup Celsius cuts 75% of staff ahead of first trial start

Guidelines to prevent youth baseball injuries need more muscle

Boston's new lab space is opening empty

Hepatitis C has a cure — but many Americans still lack access to it

HHS secretary Becerra pressed on Change HealthCare cyberattack

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

The cancer stories no one wants to hear

Drug repurposing or repositioning? The language matters

Medicare coverage of Wegovy, once blocked, now looks possible

hotspot

How I helped Pfizer think through the ethics of Viagra

President Biden's budget: Here's what you might have missed

The a glaring gap in research on serious mental illness and primary care

EPA limits use of carcinogenic gas for sterilizing medical devices

Readout Newsletter: Bristol, Sangamo, Gilead, and more

Group behind ProMed defends move to subscription

hotspot

Wikipedia

leisure time

focus